CSIMarket


Invo Bioscience Inc   (INVO)
Other Ticker:  
 


 

Invo Bioscience Inc

INVO's Financial Statements and Analysis



Invo Bioscience Inc increased third quarter of 2023 net loss per share of $-0.70 compare to net loss per share of $-0.21 recorded in the same quarter a year ago and improved compare to net loss per share of $-3.06 realized in previous quarter.


third quarter of 2023
Earnings Per Share Revenues
$ -0.7 $  1 Mill
$-0.49     $+1M     +314.28 %



Invo Bioscience Inc 's Revenue rose by 314.28 % in third quarter of 2023 (Sep 30 2023) year on year, to $1 million and advanced by 208.61 % sequentially.


Invo Bioscience Inc is Expected to report next financial results on April 16, 2024.

More on INVO's Income Statement



Invo Bioscience Inc 's in thethird quarter of 2023 recorded net loss of $-1.248 million, an improvement compare to net loss of $-2.550 million in III. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-2.241 million realized in previous quarter.

More on INVO's Growth

Invo Bioscience Inc Inventories
Inventories declined by -9.25 % to $0.25 million from III. Quarter a year ago, sequentially inventories fell by -9.21 %. INVO's Cash flow In the third quarter of 2023 company's net cash flow was $1 million, capital expenditures fell by -0.0030083,497.64%, to $0 millions compare to same quarter a year ago

More on INVO's Cash flow Statement


Invo Bioscience Inc does not pay out common stock dividend.

In trailing twelve-month period Invo Bioscience Inc payed $ -2.84 cash per share, on a free-cash flow basis .

.
Tangible Book value fell to $ -5.40 per share from $ -2.33.

Company issued 1.04 million shares or 142.66 % in Sep 30 2023.


More on INVO's Dividends

 Market Capitalization (Millions) 2
 Shares Outstanding (Millions) 2
 Total Debt (Millions $) 2
 Revenue (TTM) (Millions $) 2
 Net Income (TTM) (Millions $) -9
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Invo Bioscience Inc does not pay out common stock dividend.

In trailing twelve-month period Invo Bioscience Inc had negative $ -2.84 cash flow per share, on a free-cash flow basis .

.
Tangible Book value fell to $ -5.40 per share from $ -2.33.

Company issued 1.04 million shares or 142.66 % in Sep 30 2023.


More on INVO's Balance Sheets

 Market Capitalization (Millions) 2
 Shares Outstanding (Millions) 2
 Total Debt (Millions $) 2
 Revenue (TTM) (Millions $) 2
 Net Income (TTM) (Millions $) -9
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -
   


  News about Invo Bioscience Inc Earnings

INVO's Revenue Soars, Yet Profitability Remains Elusive

Invo Bioscience Inc, a medical equipment and supplies company, has rece...

Invo Bioscience Inc Shatters Industry Norms with Astonishing 116% Revenue Growth ? Financial Results Unveiled


A Wake-Up Call for Healthcare Investors in Q1 2023

Invo Bioscience Inc is a company in the Healthcare sector that recorded a cumulative net loss of $-11 mill...


Date modified: 2023-11-14T18:56:12+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com